Uğur Şahin - Wikipedia He is the co-founder and CEO of BioNTech, which developed the world’s first mRNA-based vaccine against COVID-19 [3][4] He also serves as chairman of the scientific management board of the Helmholtz Institute for Translational Oncology [de] (HI-TRON), a Mainz -based cutting-edge biopharmaceutical research laboratory he co-founded in 2018 [5]
BioNTechs leadership: Pioneers shaping the future of medicine Prof Ugur Sahin, M D , Co-Founder and CEO of BioNTech, is a physician, immunologist and leader in the development of novel approaches to fight cancer and infectious diseases Sahin is one of the world’s foremost experts on messenger ribonucleic acid (mRNA) medicines
BioNTech and Co-Founders Announce Plan to Pursue Next-Generation mRNA . . . BioNTech co-founders and mRNA technology pioneers Prof Ugur Sahin, M D , and Prof Özlem Türeci, M D , will establish their third biotechnology company following the foundation of Ganymed Pharmaceuticals in 2001 and BioNTech in 2008
Ugur Sahin - Forbes Uğur Şahin is CEO and cofounder of German biotech firm BioNTech, which partnered with Pfizer to produce the first Covid-19 vaccine approved in the US
BioNTech founders to step down and helm new mRNA startup Ugur Sahin and Özlem Türeci, who co-founded BioNTech and led its rise to prominence as a COVID-19 vaccine maker, are leaving the company to establish a new startup focused on mRNA technology BioNTech said Tuesday that Sahin and Türeci, who’ve been serving as CEO and Chief Medical Officer, respectively, will step down by the end of the year
BioNTech founders plan exit to set up new venture, shares slump BioNTech's two co-founders and leading executives will leave the COVID-19 vaccine maker by the end of the year to start a new venture, driving the German biotech's shares down more than 20%